51
|
Hernández-Fernández CP, Mercader-García P, Silvestre Salvador JF, Sánchez Pérez J, Fernández Redondo V, Miquel Miquel FJ, Ortiz de Frutos FJ, Gatica Ortega ME, Mora Fernández V, Giménez Arnau AM, Zaragoza Ninet V, González Pérez R, Sanz Sánchez T, Pastor Nieto MA, Serra Baldrich E, Córdoba Guijarro S, Heras Mendaza F, Ruiz González I, Rodríguez Serna M, Hervella Garcés M, Gallego Descalzo MÁ, García Doval I, Borrego Hernando L. Candidate Allergens for Inclusion in the Spanish Standard Series Based on Data from the Spanish Contact Dermatitis Registry. ACTAS DERMO-SIFILIOGRAFICAS 2021; 112:S0001-7310(21)00192-7. [PMID: 34029518 DOI: 10.1016/j.ad.2021.05.005] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2021] [Accepted: 05/03/2021] [Indexed: 11/29/2022] Open
Abstract
BACKGROUND Standard patch test series must be updated using objective data on allergen sensitization. The Spanish standard series was last updated in 2016 and the European series in 2019, and the inclusion of several emerging allergens needs to be evaluated. MATERIAL AND METHODS We conducted a prospective, observational, multicenter study of consecutive patients from the registry of the Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC) who were patch tested in 2019 and 2020 with linalool hydroperoxide, limonene hydroperoxide, 2-hydroxyethyl-methacrylate, benzisothiazolinone, octylisothiazolinone, textile dye mix (TDM), sodium metabisulfite, propolis, bronopol, Compositae mix II, diazolidinyl urea, imidazolidinyl urea, decyl glucoside, and lauryl glucoside. RESULTS We analyzed data for 4654 patients tested with diazolidinyl urea, imidazolidinyl urea, and bronopol, and 1890 tested with the other allergens. The values for the MOAHLFA index components were 30% for male, 18% for occupational dermatitis, 15% for atopic dermatitis, 29% for hand, 6.5% for leg, 23% for face, and 68% for age > 40 years. Sensitization rates above 1% were observed for 7 allergens: linalool hydroperoxide, 2-hydroxyethyl-methacrylate, benzisothiazolinone, limonene hydroperoxide, TDM, sodium metabisulfite, and propolis. Three allergens had a current relevance rate of over 1%: linalool hydroperoxide, 2-hydroxyethyl-methacrylat, and limonene hydroperoxide. Benzisothiazolinone and TDM had a relevance rate of between 0.9% and 1%. CONCLUSIONS Our results indicate that 7 new allergens should be considered when extending the Spanish standard patch test series. The data from our series could be helpful for guiding the next extension of the European baseline series.
Collapse
Affiliation(s)
- Carlos Pelayo Hernández-Fernández
- Servicio de Dermatología. Hospital Universitario de Gran Canaria Doctor Negrín. Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, España
| | - Pedro Mercader-García
- Servicio de Dermatología. Hospital General Universitario Jose Mª Morales Meseguer, Murcia, España
| | | | | | - Virginia Fernández Redondo
- Servicio de Dermatología. Complejo Hospitalario Universitario de Santiago. Universidad de Santiago de Compostela, Santiago de Compostela, España
| | | | | | | | | | - Ana María Giménez Arnau
- Servicio de Dermatología. Hospital del Mar. Instituto Municipal de Asistencia Sanitaria, Barcelona, España
| | | | - Ricardo González Pérez
- Servicio de Dermatología. Hospital Universitario Araba. Universidad del País Vasco, Vitoria, España
| | | | | | | | | | - Felipe Heras Mendaza
- Servicio de Dermatología. Hospital Universitario Fundación Jiménez Díaz, Madrid, España
| | | | | | | | | | | | - Leopoldo Borrego Hernando
- Servicio de Dermatología. Hospital Universitario Insular de Gran Canaria. Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, España.
| |
Collapse
|
52
|
Kerre S, Aerts O. Disfiguring angioedema-like airborne dermatitis from methylisothiazolinone in paints: About time to regulate? Contact Dermatitis 2021; 85:578-579. [PMID: 34018222 DOI: 10.1111/cod.13905] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2021] [Accepted: 05/12/2021] [Indexed: 11/28/2022]
Affiliation(s)
- Stefan Kerre
- Department of Dermatology, Imelda Hospital, Bonheiden, Belgium
| | - Olivier Aerts
- Department of Dermatology, University Hospital Antwerp (UZA) and Research group Immunology, Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium
| |
Collapse
|
53
|
Alves PB, Alves MP, Todo-Bom A, Regateiro FS. Concomitant allergic contact dermatitis and aquagenic urticaria caused by personal protective equipment in a healthcare worker during the COVID-19 pandemic. Contact Dermatitis 2021; 85:471-472. [PMID: 33978247 PMCID: PMC8239518 DOI: 10.1111/cod.13897] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2021] [Revised: 04/26/2021] [Accepted: 04/28/2021] [Indexed: 12/19/2022]
Affiliation(s)
- Pedro Botelho Alves
- Allergy and Clinical Immunology Unit, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
| | - Marta Pires Alves
- Allergy and Clinical Immunology Unit, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
| | - Ana Todo-Bom
- Allergy and Clinical Immunology Unit, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
| | - Frederico S Regateiro
- Allergy and Clinical Immunology Unit, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.,Institute of Immunology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.,ICBR - Coimbra Institute for Clinical and Biomedical Research, CIBB, Faculty of Medicine, University of Coimbra, Coimbra, Portugal
| |
Collapse
|
54
|
Wilkinson SM, Badulici S, Giménez-Arnau A, Dickel H, Gonçalo M, Hervella M, Isaksson M, Johansen JD, Mahler V, Thyssen JP, Uter W. The European baseline series: Criteria for allergen inclusion (with reference to formaldehyde releasers). Contact Dermatitis 2021; 85:125-128. [PMID: 33745196 DOI: 10.1111/cod.13836] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2021] [Revised: 03/15/2021] [Accepted: 03/16/2021] [Indexed: 12/12/2022]
Abstract
Existing criteria for inclusion in the European baseline series are summarized. Additional criteria are developed to aid decision making where the current criteria do not yield an unequivocal result. These include a consideration of whether an allergen (hapten) is better placed in a special series and the frequency with which an allergen cross-reacts with existing markers in the baseline series.
Collapse
Affiliation(s)
- S Mark Wilkinson
- Department of Dermatology, Chapel Allerton CSU, Leeds Teaching Hospitals NHS Trust, Leeds, UK
| | | | - Ana Giménez-Arnau
- Department of Dermatology, Hospital del Mar, Institut Mar d'Investigacions Mediques, Universitat Autónoma, Barcelona, Spain
| | - Heinrich Dickel
- Department of Dermatology, Venereology and Allergology, Ruhr University Bochum, Bochum, Germany
| | - Margarida Gonçalo
- Clinic of Dermatology, University Hospital and Faculty of Medicine, University of Coimbra, Coimbra, Portugal
| | - Marcos Hervella
- Servicio de Dermatología, Complejo Hospitalario de Navarra, Pamplona, Spain
| | - Marléne Isaksson
- Department of Occupational and Environmental Dermatology, Lund University, Skåne University Hospital, Malmö, Sweden
| | - Jeanne D Johansen
- National Allergy Research Centre, Department of Dermatology and Allergy, Copenhagen University Hospital Herlev-Gentofte, Hellerup, Denmark
| | | | - Jacob P Thyssen
- National Allergy Research Centre, Department of Dermatology and Allergy, Copenhagen University Hospital Herlev-Gentofte, Hellerup, Denmark
| | - Wolfgang Uter
- Department of Medical Informatics, Biometry and Epidemiology, University of Erlangen/Nürnberg, Erlangen, Germany
| |
Collapse
|
55
|
Mercader-García P, Pastor-Nieto MA, Gonzalez-Perez R, Cordoba-Guijarro S, Gimenez-Arnau AM, Ruiz-Gonzalez I, Mora-Fernández V, Miquel J, Silvestre-Salvador JF, Ortiz-Frutos FJ, Sanz-Sanchez T, Rodriguez-Serna M, Perez-Feal P, Sánchez-Pérez J, Heras-Mendaza F, Serra-Baldrich E, Zaragoza-Ninet V, Hervella-Garces M, Gatica-Ortega ME, García-Doval I, Descalzo MÁ, Borrego L. Should methyldibromo glutaronitrile continue to be used in the European baseline Series? A REIDAC national cross-sectional study. Contact Dermatitis 2021; 85:572-577. [PMID: 33745152 DOI: 10.1111/cod.13837] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2021] [Revised: 03/06/2021] [Accepted: 03/15/2021] [Indexed: 12/27/2022]
Abstract
BACKGROUND Methyldibromo glutaronitrile (MDBGN) was one of the most frequent and relevant allergens found in patch testing at the beginning of this century. In 2008, this preservative was banned from cosmetics in Europe and ever since the prevalence of contact allergy to MDBGN has progressively decreased. Despite that gradual decline, MDBGN is still patch-tested in most baseline series. This study assessed the frequency of MDBGN sensitization, epidemiological characteristics of allergic patients, and the relevance of positive patch tests in a nationwide Spanish registry (REIDAC). PATIENTS AND METHODS We evaluated consecutively patch-tested patients in all participating centres. Using these data, we calculated the proportion of patients with positive patch tests to MDBGN from June 2018 to June 2020 and evaluated the relevance of the positive patch tests. RESULTS One hundred and fourteen out of 5072 (2.24 %) tested patients were sensitized to MDBGN. Clinical current relevance was confirmed in only one case. CONCLUSION Although the frequency of contact allergy to MDBGN remains high, no clinical significance was found in most of these patients (5072 tests needed to obtain one relevant positive result). The clinical usefulness of this allergen seems weak and its continued inclusion in the European baseline series is questionable. HIGHLIGHTS In 2008 methyldibromo glutaronitrile (MDBGN) was banned from cosmetics in Europe and since then, the prevalence of allergy to it has progressively decreased. Nevertheless, it is still being tested in European baseline series. This study assessed the frequency of MDBGN sensitization, epidemiological characteristics of allergic patients as well as the relevance of positive patch tests in a nationwide registry (REIDAC). The frequency of allergy to MDBGN remains high, but no clinical significance was found. Most of these patients are aged >40 years and probably represent historical sensitizations.
Collapse
Affiliation(s)
- Pedro Mercader-García
- Deparment of Dermatology, Hospital General Universitario Jose Mª Morales Meseguer, Murcia, Spain
| | | | | | | | | | | | - Verónica Mora-Fernández
- Department of Dermatology, Hospital General Universitari German Trias i Pujol, Barcelona, Spain
| | - Javier Miquel
- Department of Dermatology, Hospital Arnau de Vilanova, Valencia, Spain
| | | | | | - Tatiana Sanz-Sanchez
- Department of Dermatology, Hospital General Universitario Infanta Sofia, Madrid, Spain
| | | | - Patricia Perez-Feal
- Department of Dermatology, Complejo Hospitalario Universitario Santiago de Compostela, Santiago de Compostela, Spain
| | | | | | - Ester Serra-Baldrich
- Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
| | - Violeta Zaragoza-Ninet
- Department of Dermatology, Consorcio Hospital General Universitario de Valencia, Valencia, Spain
| | | | | | - Ignacio García-Doval
- Research Unit, Fundación Piel Sana Academia Española de Dermatología y Venereología, Madrid, Spain
| | - Miguel Ángel Descalzo
- Research Unit, Fundación Piel Sana Academia Española de Dermatología y Venereología, Madrid, Spain
| | - Leopoldo Borrego
- Department of Dermatology, Complejo Hospitalario Universitario Insular Materno Infantil. Universidad de las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain
| | | |
Collapse
|
56
|
Dugonik A, Dugonik B, Podgorelec V, Brezočnik L. Associated positive patch test reactions to standard contact allergens: 10-year data from the Slovenian E-Surveillance System. Contact Dermatitis 2021; 85:17-25. [PMID: 33368304 DOI: 10.1111/cod.13767] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2020] [Revised: 12/11/2020] [Accepted: 12/21/2020] [Indexed: 11/30/2022]
Abstract
BACKGROUND A considerable share of patients tested with a baseline patch test series respond with a positive reaction to more than one allergen, and some associations between synchronous positive reactions to distinct baseline patch allergens have been described in the literature. OBJECTIVES To evaluate the prevalence of sensitization to haptens of the European baseline series as well as the prevalence of oligosensitization and polysensitization and the most significant associated positive patch test reactions in Slovenia. METHODS Patch testing data collected by the Slovenian E-Surveillance System from January 2008 to December 2017 were retrospectively analysed. RESULTS Of a total of 15 171 patients analysed, 39.29% showed at least one positive reaction. The highest prevalences were noted for metals (nickel[II]sulfate hexahydrate: 16.33%) and fragrances (fragrance mix I: 6.70%). The correlation analysis showed the strongest correlation between mercapto mix and 2-mercaptobenzothiazole (61.2%), fragrance Mix II and hydroxyisohexyl 3-cyclohexene carboxaldehyde (50.5%), and potassium dichromate and cobalt(II) chloride hexahydrate (33.3%). CONCLUSIONS Sensitization prevalences to the most common haptens were described, and their strongest correlations on a national level quantified. A comparison with other European results confirms already known associations between allergens in terms of cross-reactivity.
Collapse
Affiliation(s)
| | - Bogdan Dugonik
- Faculty of Electrical Engineering and Computer Science, University of Maribor, Maribor, Slovenia
| | - Vili Podgorelec
- Faculty of Electrical Engineering and Computer Science, University of Maribor, Maribor, Slovenia
| | - Lucija Brezočnik
- Faculty of Electrical Engineering and Computer Science, University of Maribor, Maribor, Slovenia
| |
Collapse
|
57
|
Soriano LF, Chowdhury MMU, Cooper SM, Cousen P, Dawe S, Havelin A, Holden CR, Johnston GA, Orton DI, Ramoutar A, Stone NM, Thompson DA, Buckley DA. Current prevalence and relevance of positive patch test reactions to cosmetic and noncosmetic isothiazolinones in the UK. Br J Dermatol 2021; 185:223-225. [PMID: 33657657 DOI: 10.1111/bjd.19898] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2021] [Revised: 02/26/2021] [Accepted: 02/27/2021] [Indexed: 11/28/2022]
Affiliation(s)
| | | | | | - P Cousen
- The James Cook University Hospital, Middlesbrough, TS4 3BW, UK
| | - S Dawe
- West Hertfordshire Hospitals NHS Trust, UK
| | - A Havelin
- The James Cook University Hospital, Middlesbrough, TS4 3BW, UK
| | - C R Holden
- Sheffield Teaching Hospital NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, S10 2JF, UK
| | - G A Johnston
- Leicester Royal Infirmary, Leicester, LE1 5WW, UK
| | - D I Orton
- 152 Harley St, Marylebone, London, W1G 7LH, UK
| | - A Ramoutar
- Sheffield Teaching Hospital NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, S10 2JF, UK
| | - N M Stone
- Royal Gwent Hospital, Newport, NP20 2UB, UK
| | - D A Thompson
- Birmingham Skin Centre, Sandwell and West Birmingham Hospitals NHS Trust, City Hospital, Birmingham, B18 7QH, UK
| | | |
Collapse
|
58
|
Abstract
Nickel remains the most commonly identified contact allergen. However, it has proven difficult to demonstrate significant skin-sensitizing activity for nickel in toxicology tests, which typically have indicated a weak skin sensitization potential. Information indicates that in vivo assays are not predictive of dermal sensitization hazard or potency for nickel due to a human-specific mechanistic route for nickel sensitization that animals lack. A similar rationale will apply to in vitro alternatives-although these currently have limited ability to determine intrinsic potency. Generally, in silico methods are not designed for metal allergens and cannot contribute to the analysis. For ethical reasons, human experimental work has been limited, with a single study suggesting moderate potency. Accordingly, it seems reasonable to conclude that the high frequency of contact allergy to nickel in humans is a function of both its intermediate potency coupled with a high level of dermal exposure, particularly to damaged/inflamed skin.
Collapse
Affiliation(s)
- David Basketter
- From the DABMEB Consultancy Ltd, Bedfordshire, United Kingdom
| |
Collapse
|
59
|
Pastor-Nieto MA, Gatica-Ortega ME, Sánchez-Herreros C, Vergara-Sánchez A, Martínez-Mariscal J, De Eusebio-Murillo E. Sensitization to benzyl salicylate and other allergens in patients with frontal fibrosing alopecia. Contact Dermatitis 2021; 84:423-430. [PMID: 33351203 DOI: 10.1111/cod.13763] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2020] [Revised: 12/13/2020] [Accepted: 12/16/2020] [Indexed: 01/26/2023]
Abstract
BACKGROUND Contact sensitization is frequent among patients with frontal fibrosing alopecia (FFA) (52%-76%). OBJECTIVE To evaluate the frequency of sensitization/photosensitization in an FFA population. METHODS A population of FFA patients were patch tested (Spanish Contact Dermatitis Research Group [GEIDAC] baseline; cosmetic and fragrance series), and photopatch tested (sunscreen series). RESULTS Thirty-six patients (mean age: 64.6 years; 35/36: women) were studied. A history of dermatitis was recorded in 69.4% (frequently involving the face). Overall, 80.5% patients showed positive patch-test reactions. The most frequently positive allergens were nickel sulfate (25%), benzyl salicylate (22%), gallates (16.6%), propolis (16.6%), and limonene hydroperoxides (13.8%). Benzyl salicylate was likely relevant to the dermatitis (labeled on personal care products and most patients reporting clinical improvement with allergen avoidance). Patch tests with sunscreens showed positive reactions to 11 materials (five patients). Photopatch tests were positive in one case. CONCLUSION We speculate a possible relationship between sensitization to benzyl salicylate and FFA. Hypothetically, the most likely explanation is that sensitization to benzyl salicylate involving FFA patients is a consequence of increased exposure to it. It is unclear whether allergen avoidance may impact the prognosis of alopecia. However, it seems to significantly improve the patients´ quality of life by lessening dermatitis and pruritus.
Collapse
Affiliation(s)
- María A Pastor-Nieto
- Dermatology Department, Hospital Universitario de Guadalajara, Spain.,Department of Medicine and Medicine Specialties, Faculty of Medicine and Health Sciences, Alcalá University, Alcalá de Henares, Spain
| | - María E Gatica-Ortega
- Dermatology Department, Complejo Hospitalario Universitario de Toledo, Toledo, Spain
| | | | | | | | - Esther De Eusebio-Murillo
- Dermatology Department, Hospital Universitario de Guadalajara, Spain.,Department of Medicine and Medicine Specialties, Faculty of Medicine and Health Sciences, Alcalá University, Alcalá de Henares, Spain
| |
Collapse
|
60
|
Uter W, Worm M, Brans R, Wagner N, Bauer A, Geier J. Patch test results with caine mix III and its three constituents in consecutive patients of the IVDK. Contact Dermatitis 2021; 84:481-483. [PMID: 33400817 DOI: 10.1111/cod.13778] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2020] [Revised: 12/30/2020] [Accepted: 01/02/2021] [Indexed: 11/29/2022]
Affiliation(s)
- Wolfgang Uter
- Department of Medical Informatics, Biometry and Epidemiology, University of Erlangen/Nürnberg, Erlangen, Germany
| | - Margitta Worm
- Division of Allergy and Immunology, Department of Dermatology, Venereology and Allergy, Charité -Universitätsmedizin Berlin, Berlin, Germany
| | - Richard Brans
- Department of Dermatology, Environmental Medicine and Health Theory, University of Osnabrück, Osnabrück, Germany.,Institute for Interdisciplinary Dermatological Prevention and Rehabilitation (iDerm) at the University of Osnabrück, Osnabrück, Germany
| | - Nicola Wagner
- Department of Dermatology, University Hospital Erlangen, Medical Faculty Friedrich-Alexander University, Erlangen/Nürnberg, Germany
| | - Andrea Bauer
- Department of Dermatology, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany
| | - Johannes Geier
- Information Network of Departments of Dermatology (IVDK), Institute at the University Medical Center Göttingen, Göttingen, Germany
| | | |
Collapse
|
61
|
Murphy VL, Patel DC, Lamb SR, Cheng HS. Topical corticosteroid allergy: Results of sequential testing to a corticosteroid series in New Zealand. Contact Dermatitis 2021; 85:32-38. [PMID: 33400819 DOI: 10.1111/cod.13776] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2020] [Revised: 12/26/2020] [Accepted: 12/30/2020] [Indexed: 11/29/2022]
Abstract
BACKGROUND Our institution tests the European Baseline Series (EBS) and a steroid series sequentially in all patients presenting for patch testing. The rate of steroid sensitization in New Zealand has not previously been documented. OBJECTIVES To investigate the rate of corticosteroid sensitization and assess additional benefit of testing the full steroid series over the steroid allergy markers in the EBS. METHODS/PATIENTS Retrospective analysis of all patient demographics and patch test results over a 5-year period (2014 to 2019) was performed at a tertiary patch test clinic in Auckland, New Zealand. RESULTS A total of 319 patients completed patch testing, and 4.4% were sensitized to one or more corticosteroids. As much as 79% of positive reactions were of current relevance; 11/14 reactions were to tixocortol pivalate or budesonide. The "number needed to test" to detect one additional case of corticosteroid sensitization by using the full corticosteroid series over the EBS alone was 107. CONCLUSIONS Although corticosteroid sensitization was not uncommon in our population, the results suggest that sequential testing with the corticosteroid markers (budesonide and tixocortol) in the standard series alone is adequate. The additional corticosteroid series should be added if the markers are positive or where there is a clinical suspicion of corticosteroid allergy.
Collapse
Affiliation(s)
- Victoria L Murphy
- Department of Medicine, University of Auckland, Auckland, New Zealand
| | - Denesh C Patel
- Department of Medicine, University of Auckland, Auckland, New Zealand.,Department of Dermatology, Auckland City Hospital, Auckland, New Zealand
| | - Steven R Lamb
- Department of Medicine, University of Auckland, Auckland, New Zealand.,Department of Dermatology, Auckland City Hospital, Auckland, New Zealand
| | - Harriet S Cheng
- Department of Medicine, University of Auckland, Auckland, New Zealand.,Department of Dermatology, Auckland City Hospital, Auckland, New Zealand
| |
Collapse
|
62
|
Silverberg JI, Warshaw EM, Maibach HI, DeKoven JG, Taylor JS, Atwater AR, Sasseville D, Zug KA, Reeder MJ, Fowler JF, Pratt MD, Fransway AF, Zirwas MJ, Belsito DV, Marks JG, DeLeo VA. Hand eczema in children referred for patch testing: North American Contact Dermatitis Group Data, 2000-2016. Br J Dermatol 2021; 185:185-194. [PMID: 33454963 DOI: 10.1111/bjd.19818] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/13/2021] [Indexed: 01/01/2023]
Abstract
BACKGROUND Little is known about the aetiologies and relevant allergens in paediatric patients with hand eczema (HE). OBJECTIVES To characterize the aetiologies and determine the proportion of positive and currently relevant allergens in children/adolescents (age < 18 years) with HE referred for patch testing. METHODS A retrospective analysis (2000-2016) of North American Contact Dermatitis Group data was performed. RESULTS Of 1634 paediatric patients, 237 (14·5%) had involvement of the hands. Final physician diagnoses included allergic contact dermatitis (49·4%), atopic dermatitis (37·1%) and irritant contact dermatitis (16·9%). In multivariable logistic regression models, employment was the only association with increased odds of any HE or primary HE. Children with HE vs. those without HE had similar proportions of positive patch tests (56·1% vs. 61·7%; χ2 -test, P = 0·11). The five most common currently relevant allergens were nickel, methylisothiazolinone, propylene glycol, decyl glucoside and lanolin. In multivariable logistic regression models of the top 20 relevant allergens, HE was associated with significantly higher odds of currently relevant reactions to lanolin, quaternium-15, Compositae mix, thiuram mix, 2-mercaptobenzathiazole and colophony. The allergens with the highest mean significance-prevalence index number were methylisothiazolinone, carba mix, thiuram mix, nickel and methylchloroisothiazolinone/methylisothiazolinone. CONCLUSIONS Children with HE who were referred for patch testing had a high proportion of positive patch tests, which was similar to the proportion found in children without HE. Children with HE had a distinct and fairly narrow profile of currently relevant allergens.
Collapse
Affiliation(s)
- J I Silverberg
- Department of Dermatology, The George Washington University School of Medicine and Health Sciences, Washington, DC, USA.,Department of Dermatology, The Northwestern University Feinberg School of Medicine, Chicago, IL, USA
| | - E M Warshaw
- Department of Dermatology, Park Nicollet Health Services, Minneapolis, MN, USA.,Department of Dermatology, University of Minnesota, Minneapolis, MN, USA.,Department of Dermatology, Minneapolis Veterans Affairs Medical Center, Minneapolis, MN, USA
| | - H I Maibach
- Department of Dermatology, University of California San Francisco, San Francisco, CA, USA
| | - J G DeKoven
- Division of Dermatology, Sunnybrook Health Sciences Centre, University of Toronto, ON, Canada
| | - J S Taylor
- Department of Dermatology, Cleveland Clinic, OH, USA
| | - A R Atwater
- Department of Dermatology, Duke University Medical Center, Durham, NC, USA
| | - D Sasseville
- Division of Dermatology, Montreal General Hospital, McGill University, Montreal, QC, Canada
| | - K A Zug
- Department of Dermatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA
| | - M J Reeder
- Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
| | - J F Fowler
- Division of Dermatology, University of Louisville, KY, USA
| | - M D Pratt
- Division of Dermatology, University of Ottawa, ON, Canada
| | | | - M J Zirwas
- Department of Dermatology, Ohio State University, Columbus, OH, USA
| | - D V Belsito
- Department of Dermatology, Columbia University, New York, NY, USA
| | - J G Marks
- Department of Dermatology, Pennsylvania State University, State College, PA, USA
| | - V A DeLeo
- Department of Dermatology, Keck School of Medicine, Los Angeles, CA, USA
| |
Collapse
|
63
|
|
64
|
Aerts O, Rustemeyer T, Wilkinson M. Comments on Various Baseline Series for Patch Testing. Contact Dermatitis 2021. [DOI: 10.1007/978-3-030-36335-2_95] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
65
|
Contact Allergy to Topical Drugs. Contact Dermatitis 2021. [DOI: 10.1007/978-3-030-36335-2_38] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
66
|
The North American Baseline Series. Contact Dermatitis 2021. [DOI: 10.1007/978-3-030-36335-2_66] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
67
|
The European Baseline Series. Contact Dermatitis 2021. [DOI: 10.1007/978-3-030-36335-2_64] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
68
|
Contact Allergy to Fragrances. Contact Dermatitis 2021. [DOI: 10.1007/978-3-030-36335-2_86] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
69
|
|
70
|
|
71
|
Sterkens A, Dendooven E, Lambert J, Aerts O. Hand dermatitis from daylight curing "hybrid" gel nail polish. Contact Dermatitis 2020; 84:449-450. [PMID: 33241865 DOI: 10.1111/cod.13751] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2020] [Accepted: 11/19/2020] [Indexed: 01/15/2023]
Affiliation(s)
- Ann Sterkens
- Department of Dermatology, University Hospital Antwerp (UZA), Antwerp, Belgium
| | - Ella Dendooven
- Department of Dermatology, University Hospital Antwerp (UZA), Antwerp, Belgium.,University of Antwerp, Research group Immunology, Infla-Med Centre of Excellence, Antwerp, Belgium
| | - Julien Lambert
- Department of Dermatology, University Hospital Antwerp (UZA), Antwerp, Belgium.,University of Antwerp, Research group Immunology, Infla-Med Centre of Excellence, Antwerp, Belgium
| | - Olivier Aerts
- Department of Dermatology, University Hospital Antwerp (UZA), Antwerp, Belgium.,University of Antwerp, Research group Immunology, Infla-Med Centre of Excellence, Antwerp, Belgium
| |
Collapse
|
72
|
Yüksel YT, Sedeh FB, Brans R, Svedman C, Paulsen E, Gimenéz-Arnau A, Foti C, Agner T. Value of photo assessment in late patch test readings-A multicenter study from six European patch test clinics. Contact Dermatitis 2020; 84:283-289. [PMID: 33152126 DOI: 10.1111/cod.13736] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2020] [Revised: 10/21/2020] [Accepted: 10/27/2020] [Indexed: 12/28/2022]
Abstract
BACKGROUND It is recommended that patch test readings include a day (D)7 reading. Substitution of the D7 reading with a photo may be a valid option. OBJECTIVES To compare the sensitivity of digital photos at D7 to clinical readings, to assess the number of positive reactions appearing at D7 only (late reactions), and after D7 only (delayed reactions). METHODS Patients patch tested in six European clinics were instructed to forward photos of the patch test reactions to the respective clinics at D7 (before attending the clinic) and at D21. Only allergens in the baseline series or TRUE Test were included in the data analysis. RESULTS Two hundred ninety-three of 629 patients had a total of 599 positive reactions, with 6.3% occurring at D7 only. When substituting the D7 reading with a photo (90% submitted), 26.3% of late reactions were missed and nine false-positive reactions were found. Delayed reactions were detected in four patients at D21 (65.3% submitted). CONCLUSION Our data show that if the D7 reading is not performed, 6.3% of positive reactions from the baseline series would be missed, and if substituting the D7 reading by digital photo, 26.3% late reactions would be missed. Delayed reactions seemed rare.
Collapse
Affiliation(s)
- Yasemin T Yüksel
- Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark
| | - Farnam B Sedeh
- Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark
| | - Richard Brans
- Department of Dermatology, Environmental Medicine and Health Theory, University of Osnabrück, Osnabrück, Germany
| | - Cecilia Svedman
- Department of Occupational Dermatology, University of Lund, Skåne University Hospital, Malmö, Sweden
| | - Evy Paulsen
- Department of Dermatology and Allergy Centre, Odense University Hospital, University of Southern Denmark, Odense, Denmark
| | - Ana Gimenéz-Arnau
- Department of Dermatology, Hospital del Mar, IMIM, Universitat Autònoma de Barcelona, Barcelona, Spain
| | - Caterina Foti
- Department of Biomedical Science and Human Oncology, Dermatological Clinic, University of Bari, Bari, Italy
| | - Tove Agner
- Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark
| | | |
Collapse
|
73
|
Di Altobrando A, La Placa M, Neri I, Piraccini BM, Vincenzi C. Contact dermatitis due to masks and respirators during
COVID
‐19 pandemic: What we should know and what we should do. Dermatol Ther 2020; 33:e14528. [DOI: 10.1111/dth.14528] [Citation(s) in RCA: 16] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2020] [Accepted: 11/06/2020] [Indexed: 12/13/2022]
Affiliation(s)
- Ambra Di Altobrando
- Department of Experimental, Diagnostic and Specialty Medicine, Division of Dermatology University of Bologna Bologna Italy
| | - Michelangelo La Placa
- Department of Experimental, Diagnostic and Specialty Medicine, Division of Dermatology University of Bologna Bologna Italy
| | - Iria Neri
- Department of Experimental, Diagnostic and Specialty Medicine, Division of Dermatology University of Bologna Bologna Italy
| | - Bianca Maria Piraccini
- Department of Experimental, Diagnostic and Specialty Medicine, Division of Dermatology University of Bologna Bologna Italy
| | - Colombina Vincenzi
- Department of Experimental, Diagnostic and Specialty Medicine, Division of Dermatology University of Bologna Bologna Italy
| |
Collapse
|
74
|
Darrigade AS, Dendooven E, Mangodt E, Aerts O. Delayed-type hypersensitivity to secukinumab with tolerance to ixekizumab. THE JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. IN PRACTICE 2020; 8:3626-3628. [PMID: 32585409 DOI: 10.1016/j.jaip.2020.06.016] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/16/2020] [Revised: 06/03/2020] [Accepted: 06/05/2020] [Indexed: 12/23/2022]
Affiliation(s)
- Anne-Sophie Darrigade
- Department of Dermatology, Contact Allergy Unit, University Hospital Antwerp (UZA) and University of Antwerp (UA), Wilrijkstraat, Antwerp, Belgium
| | - Ella Dendooven
- Department of Dermatology, Contact Allergy Unit, University Hospital Antwerp (UZA) and University of Antwerp (UA), Wilrijkstraat, Antwerp, Belgium
| | - Evelyne Mangodt
- Department of Dermatology, Contact Allergy Unit, University Hospital Antwerp (UZA) and University of Antwerp (UA), Wilrijkstraat, Antwerp, Belgium
| | - Olivier Aerts
- Department of Dermatology, Contact Allergy Unit, University Hospital Antwerp (UZA) and University of Antwerp (UA), Wilrijkstraat, Antwerp, Belgium.
| |
Collapse
|
75
|
Cao T, Gao Y, Li L, Zou Y, Maibach HI. Changes in Chinese patch testing practices over 13 years: Updated cross-sectional survey and possible international implications. Contact Dermatitis 2020; 84:159-165. [PMID: 32939764 DOI: 10.1111/cod.13701] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2020] [Revised: 08/31/2020] [Accepted: 09/13/2020] [Indexed: 11/30/2022]
Abstract
BACKGROUND Patch testing, the standard method for diagnosing allergic contact dermatitis, has been utilized for over 30 years in China. A 2006 survey found that patch testing was widespread among Chinese dermatologists, but the practice and perceptions were unsatisfactory. OBJECTIVE To evaluate the current situation of patch testing practice and perception, we resurveyed Chinese dermatologists. METHODS A cross-sectional survey of Chinese dermatologists was conducted by electronic questionnaires at the 15th National Congress of Dermatology in November 2019. RESULTS There were 2199 valid questionnaires collected. About 75% of dermatologists performed patch testing; the majority (59.2%) utilized the baseline (standard) allergen series made in China; others used TRUE Test or the Chemotechnique Diagnostics series, a greater share compared with 2006. Most (92.8%) performed only one single reading, more than 2006. About two-thirds offered patient education after patch testing, but only 27% were executed by trained dermatologists. Dermatologists from regional hospitals more likely performed patch testing and had better perception of patch testing. The majority (88.1%) had received patch testing training, which however did not significantly improve dermatologists' perception. CONCLUSIONS There was an insignificant improvement in practice and perception of dermatologists compared with 2006. Further education and studies should be conducted. Similar surveys in other countries would be of interest.
Collapse
Affiliation(s)
- Ting Cao
- Skin and Cosmetic Research Department, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China
| | - Yanrui Gao
- Skin and Cosmetic Research Department, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China
| | - Linfeng Li
- Skin and Cosmetic Research Department, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China.,Department of Dermatology, Allergy and Clinical Immunology Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China
| | - Ying Zou
- Skin and Cosmetic Research Department, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China
| | - Howard I Maibach
- Department of Dermatology, School of Medicine, University of California, San Francisco, California, USA
| |
Collapse
|
76
|
Soriano LF, Bertram CG, Chowdhury MMU, Cousen P, Divekar P, Ghaffar SA, Green C, Havelin A, Holden CR, Johnston GA, Mughal AA, Nic Dhonncha E, Sabroe RA, Stone NM, Thompson DA, Wilkinson SM, Buckley DA. Prevalence of allergic contact dermatitis to decyl and lauryl glucoside in the UK and Ireland. Br J Dermatol 2020; 184:571-573. [PMID: 33090453 DOI: 10.1111/bjd.19603] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2020] [Revised: 10/08/2020] [Accepted: 10/11/2020] [Indexed: 01/27/2023]
Affiliation(s)
| | - C G Bertram
- Royal Infirmary of Edinburgh, Edinburgh, EH16 4SA, UK
| | | | - P Cousen
- The James Cook University Hospital, Middlesbrough, TS4 3BW, UK
| | - P Divekar
- Royal Cornwall Hospitals NHS Trust, Truro, Cornwall, TR1 3LJ, UK
| | | | - C Green
- Ninewells Hospital, Dundee, DD2 1SG, UK
| | - A Havelin
- The James Cook University Hospital, Middlesbrough, TS4 3BW, UK
| | - C R Holden
- Sheffield Teaching Hospital NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, S10 2JF, UK
| | - G A Johnston
- Leicester Royal Infirmary, Leicester, LE1 5WW, UK
| | - A A Mughal
- Singleton Hospital, Swansea, SA2 8QA, UK
| | - E Nic Dhonncha
- South Infirmary Victoria University Hospital, Cork, T12 X23H, Ireland
| | - R A Sabroe
- Sheffield Teaching Hospital NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, S10 2JF, UK
| | - N M Stone
- Royal Gwent Hospital, Newport, NP20 2UB, UK
| | - D A Thompson
- Birmingham Skin Centre, Sandwell and West Birmingham Hospitals NHS Trust, City Hospital, Birmingham, B18 7QH, UK
| | | | | |
Collapse
|
77
|
Dendooven E, Foubert K, Goossens A, Gilles P, De Borggraeve W, Pieters L, Lambert J, Aerts O. Concomitant positive patch test reactions in FreeStyle-allergic patients sensitized to isobornyl acrylate. Contact Dermatitis 2020; 84:166-174. [PMID: 32965058 DOI: 10.1111/cod.13706] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2020] [Revised: 08/28/2020] [Accepted: 08/31/2020] [Indexed: 12/15/2022]
Abstract
BACKGROUND Concomitant positive patch test reactions in patients sensitized to isobornyl acrylate (IBOA) have rarely been documented. OBJECTIVES To report concomitant sensitizations in patients with allergic contact dermatitis (ACD) from the glucose sensor FreeStyle Libre and sensitized to IBOA. METHODS In 2019, 26 patients with suspected ACD from FreeStyle Libre were patch tested to a baseline series and to a (meth) acrylate series containing IBOA and 2-phenoxyethyl acrylate (PEA) 0.1% pet. Diabetes devices and patch test preparations were analyzed with gas chromatography - mass spectrometry (GC-MS) for the presence of IBOA and PEA. RESULTS Of the 26 patients, 18 (69%) were sensitized to IBOA, and eight (44%) and 11 (61%) of these were co-sensitized to sesquiterpene lactones and fragrances, respectively. Ten patients (56%) were co-sensitized to PEA, which, contrary to IBOA, could not be detected in any device. The PEA test material was shown to be contaminated with IBOA. CONCLUSIONS Contact allergy to IBOA appears to be declining and IBOA-sensitized patients are most often co-sensitized to sesquiterpene lactones and fragrances. Vigilance is required when patch testing (acrylate) materials obtained from industry, as these might be contaminated and, hence, alter the results and their interpretation.
Collapse
Affiliation(s)
- Ella Dendooven
- Department of Dermatology, University Hospital Antwerp (UZA), Antwerp, Belgium.,Research Group Immunology, Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium.,Research Group Natural Products and Food - Research and Analysis (NatuRA), Department of Pharmaceutical Sciences, University of Antwerp (UA), Antwerp, Belgium
| | - Kenn Foubert
- Research Group Natural Products and Food - Research and Analysis (NatuRA), Department of Pharmaceutical Sciences, University of Antwerp (UA), Antwerp, Belgium
| | - An Goossens
- Department of Dermatology, University Hospitals KU Leuven, Leuven, Belgium
| | - Philippe Gilles
- Molecular Design and Synthesis, Department of Chemistry, KU Leuven, Leuven, Belgium
| | - Wim De Borggraeve
- Molecular Design and Synthesis, Department of Chemistry, KU Leuven, Leuven, Belgium
| | - Luc Pieters
- Research Group Natural Products and Food - Research and Analysis (NatuRA), Department of Pharmaceutical Sciences, University of Antwerp (UA), Antwerp, Belgium
| | - Julien Lambert
- Department of Dermatology, University Hospital Antwerp (UZA), Antwerp, Belgium.,Research Group Immunology, Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium
| | - Olivier Aerts
- Department of Dermatology, University Hospital Antwerp (UZA), Antwerp, Belgium.,Research Group Immunology, Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium
| |
Collapse
|
78
|
The Effect of Atopy in the Prevalence of Contact Sensitization: The Experience of a Greek Referral Center. Dermatol Res Pract 2020; 2020:3946084. [PMID: 33133180 PMCID: PMC7568788 DOI: 10.1155/2020/3946084] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2020] [Revised: 07/05/2020] [Accepted: 08/24/2020] [Indexed: 12/13/2022] Open
Abstract
Contact dermatitis is a well-known skin condition, which is related to stimuli and environmental exposure to chemicals, affecting all ages as well as both genders. In the present work, we attempt to investigate the patterns of contact sensitization, with respect to the personal history of atopy (AT), in Greece in a large number of allergens, using patch testing. The retrospective analysis included clinical routine data of 1978 patients collected from 2014 to 2016 in the Laboratory of Patch Testing, National Referral Centre of Occupational Dermatoses. Sensitization, in all cases, was tested with 28 allergens of the European baseline series as adjusted to our local circumstances and clinical experience. A total population of 1978 patients was evaluated, with a male-to-female ratio of 0.45 (1359 females/619 males). From our patient cohort, 693 (35%) patients were evaluated with a history of atopy, while 1285 (65%) were nonatopic. The five most prevalent allergens in the total population without AT were nickel sulphate 5% (15.47%), fragrance mix (I) 8% (9.10%), balsam of Peru (6.47%), cobalt chloride 1% (4.70%), and thiomersal 0.1% (4.10%). Respectively, in the total population with AT, the five most prevalent allergens were nickel sulphate 5% (10.36%), fragrance mix (I) 8% (5.11%), balsam of Peru (3.29%), thiomersal 0.1% (3.03%), and cobalt chloride 1% (2.78%). Contact dermatitis surveillance is of great importance towards the clinical and systematic understanding of the disease. Further studies should be directed towards that end, in order to facilitate more effective health policies.
Collapse
|
79
|
Uter W, Bauer A, Belloni Fortina A, Bircher AJ, Brans R, Buhl T, Cooper SM, Czarnecka-Operacz M, Dickel H, Dugonik A, Geier J, Giménez-Arnau AM, Gonçalo M, Johansen JD, Johnston GA, Mahler V, Rustemeyer T, Sanchez-Perez J, Schuttelaar MLA, Simon D, Spiewak R, Valiukevičienė S, Weisshaar E, White IR, Wilkinson M. Patch test results with the European baseline series and additions thereof in the ESSCA network, 2015-2018. Contact Dermatitis 2020; 84:109-120. [PMID: 32945543 DOI: 10.1111/cod.13704] [Citation(s) in RCA: 42] [Impact Index Per Article: 10.5] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2020] [Accepted: 09/12/2020] [Indexed: 02/06/2023]
Abstract
BACKGROUND Clinical surveillance of the prevalence of contact allergy in consecutively patch tested patients is a proven instrument to continually assess the importance of contact allergens (haptens) assembled in a baseline series. OBJECTIVES To present current results from the European Surveillance System on Contact Allergies, including 13 countries represented by 1 to 11 departments. METHODS Anonymized or pseudonymized patch test and clinical data from various data capture systems used locally or nationally as transferred to the Erlangen data centre were pooled and descriptively analysed after quality control. RESULTS In the 4 years (2015-2018), data from 51 914 patients patch tested with the European baseline series (EBS) of contact allergens were analysed. Contact allergy to nickel was most frequent (17.6% positive), followed by contact allergy to fragrance mix I (6.9%), methylisothiazolinone (MI; 6.2%), and Myroxylon pereirae resin (balsam of Peru; 5.8%). CONCLUSIONS While the prevalence of MI contact allergy decreased substantially following regulatory intervention, the persistently high levels of allergy to metals, fragrances, other preservatives, and rubber chemicals point to problems needing further research and, potentially, preventive efforts. Results with national additions to the baseline series provide important information on substances possibly to be considered for inclusion in the EBS.
Collapse
Affiliation(s)
- Wolfgang Uter
- Department of Medical Informatics, Biometry and Epidemiology, University of Erlangen/Nürnberg, Erlangen, Germany
| | - Andrea Bauer
- Department of Dermatology, University Allergy Centre, Medical Faculty Carl Gustav Carus, Technical University Dresden, Dresden, Germany
| | - Anna Belloni Fortina
- Dermatology Unit, Department of Paediatrics, University of Padova, Padova, Italy
| | - Andreas J Bircher
- Allergy Unit, Department of Dermatology, University Hospital Basel, Basel, Switzerland.,Faculty of Biomedicine, Università della Svizzera Italiana, Lugano, Switzerland
| | - Richard Brans
- Department of Dermatology, Environmental Medicine and Health Theory, University of Osnabrück, Osnabrück, Germany
| | - Timo Buhl
- Department of Dermatology, Venereology and Allergology, University Medical Center Göttingen, Göttingen, Germany
| | - Susan M Cooper
- Department of Dermatology, Oxford University Hospitals NHS Trust, Oxford, UK
| | | | - Heinrich Dickel
- Department of Dermatology, Venereology and Allergology, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany
| | - Aleksandra Dugonik
- Department of Dermatology, University Medical Centre Maribor, Maribor, Slovenia
| | - Johannes Geier
- Information Network of Department of Dermatology, University Medical Center, Göttingen, Germany
| | - Ana M Giménez-Arnau
- Department of Dermatology, Hospital del Mar. Universitat Autònoma and Pompeu Fabra, Barcelona, Spain
| | - Margarida Gonçalo
- Department of Dermatology, Coimbra University Hospital and Faculty of Medicine, University of Coimbra, Coimbra, Portugal
| | - Jeanne D Johansen
- National Allergy Research Centre, Department of Skin and Allergy, Gentofte Hospital, Hellerup, Denmark
| | | | - Vera Mahler
- Department of Dermatology, University Hospital Erlangen, Erlangen, Germany, Paul-Ehrlich-Institut, Langen, Germany
| | - Thomas Rustemeyer
- Department of Dermatology, Free University of Amsterdam, Amsterdam, The Netherlands
| | - Javier Sanchez-Perez
- Dermatology Department, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria la Princesa (IIS-IP), Madrid, Spain
| | - Marie L A Schuttelaar
- Department of Dermatology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
| | - Dagmar Simon
- Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
| | - Radoslaw Spiewak
- Department of Experimental Dermatology and Cosmetology, Jagiellonian University Medical College, Krakow, Poland
| | - Skaidra Valiukevičienė
- Department of Skin and Venereal Diseases, Lithuanian University of Health Sciences, Kaunas, Lithuania
| | - Elke Weisshaar
- Department of Clinical Social Medicine, Occupational and Environmental Dermatology, University Hospital Heidelberg, Heidelberg, Germany
| | - Ian R White
- Cutaneous Allergy Team, St. John's Institute of Dermatology, Guy's Hospital, London, UK
| | - Mark Wilkinson
- Dermatology Department, Leeds Teaching Hospitals NHS Trust, Leeds, UK
| | | |
Collapse
|
80
|
Popov TA, Passalacqua G, González-Díaz SN, Plavec D, Braido F, García-Abujeta JL, Dubuske L, Rouadi P, Morais-Almeida M, Bonini S, Cheng L, Ansotegui IJ. Medical devices in allergy practice. World Allergy Organ J 2020; 13:100466. [PMID: 33024482 PMCID: PMC7529824 DOI: 10.1016/j.waojou.2020.100466] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2020] [Revised: 08/22/2020] [Accepted: 09/03/2020] [Indexed: 12/12/2022] Open
Abstract
Medical devices provide people with some health benefits in terms of diagnosis, prevention, treatment, and monitoring of disease processes. Different medical specialties use varieties of medical devices more or less specific for them. Allergology is an interdisciplinary field of medical science and teaches that allergic reactions are of systemic nature but can express themselves at the level of different organs across the life cycle of an individual. Subsequently, medical devices used in allergology could be regarded as: 1) general, servicing the integral diagnostic and management principles and features of allergology, and 2) organ specific, which are shared by organ specific disciplines like pulmonology, otorhinolaryngology, dermatology, and others. The present position paper of the World Allergy Organization (WAO) is meant to be the first integral document providing structured information on medical devices in allergology used in daily routine but also needed for sophisticated diagnostic purposes and modern disease management. It is supposed to contribute to the transformation of the health care system into integrated care pathways for interrelated comorbidities.
Collapse
Key Words
- AAP, Asthma Action Plan
- ATS, American Thoracic Society
- Airway inflammation
- Allergic rhinitis
- Allergology
- Allergy
- Allergy diagnosis
- Asthma
- CE mark, Conformité Européenne mark
- CO, Carbon monoxide
- DPIs, Dry Powder Inhalers
- EAI/AAI, Epinephrine/Adrenaline Auto-Injector
- EBC, Exhaled Breath Condensate
- EBT, Exhaled Breath Temperature
- EDS, Exhalation Delivery Systems
- EMA, European Medicines Agency
- ERS, European Respiratory Society
- ERV, Expiratory Reserve Volume
- FDA, Food and Drug Administration
- FEF, Forced Expiratory Flows
- FEV1, Forced Expiratory Volume in 1 second
- FOT, Forced Oscillation Technique
- FRC, Functional Residual Capacity
- FVC, Forced Vital Capacity
- FeNO, Fractional Exhaled Nitric Oxide
- GLI, Global Lung Function Initiative
- IOS, Impulse Oscillometry
- IRV, Inspiratory Reserve Volume
- Lung function tests
- MDPS, Metered-Dose Pump Sprays
- Medical devices
- NDDD, Nasal Drug Delivery Device
- NO, Nitric oxide
- PDMI, Pressurized Metered Dose Inhaler
- PEF, Peak Expiratory Flow
- PNIF, Peak Nasal Inspiratory Flow
- PT, Patch Tests
- PhPT, Photopatch tests
- Ppb, part per billion
- RV, Residual Volume
- SPT, Skin Prick Test
- Skin tests
- TLC, Total Lung Capacity
- UV, Ultra Violet
- VC, Vital Capacity
- VT, Tidal Volume
- WAO, World Allergy Organization
- WHO, World Health Organization
- m-health
Collapse
Affiliation(s)
| | | | | | | | | | | | - Lawrence Dubuske
- The George Washington University School of Medicine, Washington DC, USA
| | | | | | - Sergio Bonini
- Institute of Translational Pharmacology, Italian National Research Council, Rome, Italy
| | - Lei Cheng
- Nanjing Medical University, First Affiliated Hospital, Nanjing, China
| | | |
Collapse
|
81
|
Horton E, Uter W, Geier J, Ballmer-Weber B, Bauer A, Bircher A, Dickel H, Giménez-Arnau A, Gonçalo M, John SM, Mahler V, Schuttelaar MLA, Simon D, Sanchez-Perez J, Rustemeyer T, Weisshaar E, Wilkinson M. Developing a cosmetic series: Results from the ESSCA network, 2009-2018. Contact Dermatitis 2020; 84:82-94. [PMID: 32845019 DOI: 10.1111/cod.13690] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2020] [Revised: 07/24/2020] [Accepted: 08/18/2020] [Indexed: 12/31/2022]
Abstract
BACKGROUND There is considerable variability across European patch test centres as to which allergens are included in local and national cosmetics series. OBJECTIVES To propose a standardized, evidence-based cosmetic series for Europe based on up-to-date analysis of relevant contact allergens. METHODS We collated data from the European Surveillance System on Contact Allergies (ESSCA) from 2009 to 2018 to determine which cosmetic allergens produce a high yield of contact allergy. Contact allergens with a prevalence of >0.3% that were considered relevant were included. Rare contact allergens were excluded if deemed no longer relevant or added to a supplemental cosmetic series for further analysis. RESULTS Sensitization prevalences of 39 cosmetic contact allergens were tabulated. Thirty of these allergens yielded >0.3% positive reactions and are therefore included in our proposed European cosmetic series. Six were considered no longer relevant and therefore excluded. Three were included in a supplementary European cosmetic series. An additional nine allergens were included in either the core or supplemental European cosmetic series following literature review. CONCLUSION We have derived a potential European cosmetic series based upon the above methods. This will require ongoing investigation based upon the changing exposure profiles of cosmetic allergens as well as new and evolving substances.
Collapse
Affiliation(s)
- Emma Horton
- Department of Dermatology, Chapel Allerton Hospital, Leeds, UK
| | - Wolfgang Uter
- Department of Medical Informatics, Biometry and Epidemiology, University of Erlangen/Nürnberg, Erlangen, Germany
| | - Johannes Geier
- Information Network of Departments of Dermatology (IVDK), Institute at the University Medical Center Göttingen, Göttingen, Germany
| | - Barbara Ballmer-Weber
- Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.,Department of Dermatology, Kantonsspital St. Gallen, St. Gallen, Switzerland
| | - Andrea Bauer
- Department of Dermatology, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany
| | - Andreas Bircher
- Department of Dermatology, Allergy Unit, University Hospital Basel, Basel, Switzerland
| | - Heinrich Dickel
- Department of Dermatology, Venereology and Allergology, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany
| | - Ana Giménez-Arnau
- Department of Dermatology, Hospital del Mar, Institut Mar d'Investigacions Mediques, Universitat Autónoma, Barcelona, Spain
| | - Margarida Gonçalo
- Department of Dermatology, Clinic of Dermatology, University Hospital and Faculty of Medicine, University of Coimbra, Coimbra, Portugal
| | - Swen Malte John
- Institute for Interdisciplinary Dermatologic Prevention and Rehabilitation (iDerm), University of Osnabruck, Lower Saxony Institute for Occupational Dermatology (NIB), Osnabruck, Germany
| | - Vera Mahler
- Department of Dermatology, University Hospital Erlangen, University of Erlangen-Nurnberg, Erlangen, Germany.,Department of Dermatology, Paul-Ehrlich-Institut, Langen, Germany
| | - Marie L A Schuttelaar
- Department of Dermatology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
| | - Dagmar Simon
- Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
| | | | - Thomas Rustemeyer
- Department of Dermatology, VU University, Amsterdam, The Netherlands
| | - Elke Weisshaar
- Occupational Dermatology, Department of Dermatology, Ruprecht-Karls University Heidelberg, Heidelberg, Germany
| | - Mark Wilkinson
- Department of Dermatology, Chapel Allerton Hospital, Leeds, UK
| |
Collapse
|
82
|
Russo JP, Aerts O. In vivo demonstration of immunologic cross-reactivity to octylisothiazolinone in patients primarily and strongly sensitized to methylisothiazolinone. Contact Dermatitis 2020; 83:391-397. [PMID: 32666548 DOI: 10.1111/cod.13661] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2020] [Revised: 07/05/2020] [Accepted: 07/13/2020] [Indexed: 11/28/2022]
Abstract
BACKGROUND Notwithstanding that concomitant exposure to different isothiazolinone derivatives may result in concomitant sensitization, clinical and animal studies have suggested cross-reactivity between these derivatives, notably between methylisothiazolinone (MI) and octylisothiazolinone (OIT). OBJECTIVE To investigate if patients sensitized to MI show cross-reactions to OIT and/or to benzisothiazolinone (BIT) by applying the concept of the re-test method. PATIENTS AND METHODS From March to October 2019 consecutive patients were patch tested with MI 0.2% aqueous in duplicate at the two lower corners of both shoulder blades. Patients sensitized to MI, but not to OIT 0.1% petrolatum (pet.) nor to BIT 0.1% pet., were re-tested, 2 months later, with the latter two derivatives at the skin sites where the MI reactions had fully disappeared. RESULTS Of 116 patients, 15 (13%) were sensitized to MI, eight of these not sensitized to BIT nor to OIT. Of these, seven patients, all (very) strongly sensitized to MI, were re-tested: five patients showed positive patch test reactions to OIT 0.1% pet.; one patient to OIT 0.1% pet. and BIT 0.1% pet.; and one other patient showed no reactions. CONCLUSION This study suggests that patients primarily and strongly sensitized to MI may show immunologic cross-reactions to OIT, and to a far lesser extent to BIT.
Collapse
Affiliation(s)
- Juan Pedro Russo
- Department of Dermatology, Hospital Interzonal General de Agudos San Martin de La Plata, 10 1121, La Plata, Buenos Aires, 1900, Argentina
| | - Olivier Aerts
- Department of Dermatology, University Hospital Antwerp (UZA) and University of Antwerp, Research Group Immunology, Infla-Med Centre of Excellence, Antwerp, Belgium.,Research Group Immunology, Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium
| |
Collapse
|
83
|
Alves PB, Todo-Bom A, Regateiro FS. Viola duet: A rare case of double sensitization to contact allergens in a professional musician. Contact Dermatitis 2020; 83:523-524. [PMID: 32666527 DOI: 10.1111/cod.13662] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2020] [Accepted: 07/13/2020] [Indexed: 11/27/2022]
Affiliation(s)
- Pedro B Alves
- Allergy and Clinical Immunology Unit, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
| | - Ana Todo-Bom
- Allergy and Clinical Immunology Unit, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
| | - Frederico S Regateiro
- Allergy and Clinical Immunology Unit, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.,Institute of Immunology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.,ICBR - Coimbra Institute for Clinical and Biomedical Research, CIBB, Faculty of Medicine, University of Coimbra, Coimbra, Portugal
| |
Collapse
|
84
|
Aerts O, Dendooven E, Foubert K, Stappers S, Ulicki M, Lambert J. Surgical mask dermatitis caused by formaldehyde (releasers) during the
COVID
‐19 pandemic. Contact Dermatitis 2020; 83:172-173. [DOI: 10.1111/cod.13626] [Citation(s) in RCA: 39] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2020] [Accepted: 05/27/2020] [Indexed: 12/29/2022]
Affiliation(s)
- Olivier Aerts
- Department of DermatologyUniversity Hospital Antwerp (UZA) Antwerp Belgium
- Research Group Immunology, Infla‐Med Centre of ExcellenceUniversity of Antwerp Antwerp Belgium
| | - Ella Dendooven
- Department of DermatologyUniversity Hospital Antwerp (UZA) Antwerp Belgium
- Research Group Immunology, Infla‐Med Centre of ExcellenceUniversity of Antwerp Antwerp Belgium
- Research Group Natural Products and Food – Research and Analysis (NatuRA), Department of Pharmaceutical SciencesUniversity of Antwerp (UA) Antwerp Belgium
| | - Kenn Foubert
- Research Group Natural Products and Food – Research and Analysis (NatuRA), Department of Pharmaceutical SciencesUniversity of Antwerp (UA) Antwerp Belgium
| | - Sofie Stappers
- Department of DermatologyUniversity Hospital Antwerp (UZA) Antwerp Belgium
| | - Michal Ulicki
- Department of DermatologyUniversity Hospital Antwerp (UZA) Antwerp Belgium
| | - Julien Lambert
- Department of DermatologyUniversity Hospital Antwerp (UZA) Antwerp Belgium
| |
Collapse
|
85
|
Rolls S, Owen E, Bertram CG, Bourke JF, Buckley DA, Chowdhury MMU, Cooper SM, Ghaffar SA, Green CM, Hughes TM, Johnston GA, Reckling CM, Thompson DA, Wakelin SH, Wilkinson M, Stone NM. What is in? What is out? Updating the British Society for Cutaneous Allergy facial series. Br J Dermatol 2020; 184:151-155. [PMID: 32282055 DOI: 10.1111/bjd.19127] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/27/2020] [Indexed: 01/05/2023]
Abstract
BACKGROUND Allergic contact dermatitis (ACD) to cosmetics is widely reported. To ensure we are accurately diagnosing ACD, patch test series should be continually reviewed to identify relevant and emerging allergens and highlight those that are outdated. The current British Society for Cutaneous Allergy (BSCA) facial series recommends 26 allergens and was last modified in 2012. OBJECTIVES To review and update the BSCA facial series. METHODS We retrospectively reviewed the results from 12 UK and Ireland patch test centres' facial series from January 2016 to December 2017. We recorded the number of allergens tested in each centre and the detection rate for each allergen. Using a 0·3% positive rate as the inclusion threshold, we established which allergens in the BSCA facial series had positive patch test rates < 0·3% and > 0·3%. Allergens not in the BSCA facial series that had a positive patch test rate > 0·3% were identified. RESULTS Overall, 4224 patients were patch tested to the facial series. The number of allergens included in individual centres' facial series ranged from 24 to 66, with a total of 103 allergens tested across all centres. Twelve of the 26 allergens in the BSCA facial series had a positive patch test rate < 0·3% and 14 had a rate > 0·3%. Twenty-five allergens not recommended in the BSCA facial series had a positive patch test rate > 0·3%. CONCLUSIONS This audit has highlighted the significant variation in practice that exists among patch test centres, despite a recommended facial series. The BSCA facial series has been updated and now contains 24 allergens. Fifteen allergens remain, 11 allergens have been dropped and nine new allergens have been added.
Collapse
Affiliation(s)
- S Rolls
- Royal Gwent and Nevill Hall Hospitals, Newport, UK
| | - E Owen
- Royal Gwent and Nevill Hall Hospitals, Newport, UK
| | | | - J F Bourke
- South Infirmary Victoria University Hospital, Cork, Ireland
| | | | | | | | | | | | - T M Hughes
- Royal Gwent and Nevill Hall Hospitals, Newport, UK
| | | | | | - D A Thompson
- Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK
| | - S H Wakelin
- Imperial College Healthcare NHS Trust, London, UK
| | - M Wilkinson
- Leeds Teaching Hospital NHS Trust, Leeds, UK
| | - N M Stone
- Royal Gwent and Nevill Hall Hospitals, Newport, UK
| |
Collapse
|
86
|
Contact Allergy-Emerging Allergens and Public Health Impact. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2020; 17:ijerph17072404. [PMID: 32244763 PMCID: PMC7177224 DOI: 10.3390/ijerph17072404] [Citation(s) in RCA: 26] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/03/2020] [Revised: 03/17/2020] [Accepted: 03/30/2020] [Indexed: 02/07/2023]
Abstract
Contact allergy (sensitisation) and allergic contact dermatitis (ACD) resulting from it have a considerable public health impact. For the present review, all pertinent articles were systematically searched via Medline and Web of Science™; additionally, all available issues of the journals "Contact Dermatitis" and "Dermatitis" were manually searched, covering the years 2018-2019, thereby extending and re-focusing a previous similar review. New allergens, or previously described allergens found in a new exposure context or of other current importance, are described in sections according to substance classes, e.g., metals, preservatives, fragrances. As a common finding in many investigations, a lack of information on product composition has been noted, for instance, regarding a newly described allergen in canvas shoes (dimethylthiocarbamylbenzothiazole sulfide) and, most notably, absence of co-operation from manufacturers of glucose-monitoring devices and insulin pumps, respectively. These latter devices have been shown to cause severe ACD in a considerable number of diabetic patients caused by the liberation of isobornyl acrylate and N,N'-dimethylacrylamide, respectively, as demonstrated by an international collaboration between dermatologists and chemists. Improved and complete ingredient labelling for all types of products, and not just cosmetics, must be put on the legislative agenda.
Collapse
|
87
|
Uter W, Gefeller O, Mahler V, Geier J. Trends and current spectrum of contact allergy in Central Europe: results of the Information Network of Departments of Dermatology (IVDK) 2007–2018*. Br J Dermatol 2020; 183:857-865. [DOI: 10.1111/bjd.18946] [Citation(s) in RCA: 28] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/11/2020] [Indexed: 12/30/2022]
Affiliation(s)
- W. Uter
- Department of Medical Informatics, Biometry and Epidemiology University of Erlangen/Nürnberg Erlangen Germany
| | - O. Gefeller
- Department of Medical Informatics, Biometry and Epidemiology University of Erlangen/Nürnberg Erlangen Germany
| | - V. Mahler
- Paul Ehrlich Institut Langen Germany
| | - J. Geier
- Information Network of Departments of Dermatology University Medical Center Göttingen Germany
| |
Collapse
|
88
|
Sukakul T, Limphoka P, Boonchai W. Methylchloroisothiazolinone and/or Methylisothiazolinone Contact Allergies in Thailand. Dermatitis 2020; 32:375-380. [PMID: 32209866 DOI: 10.1097/der.0000000000000537] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
BACKGROUND Methylchloroisothiazolinone, in combination with methylisothiazolinone (MCI/MI), and MI alone are common preservatives. The incidences of MCI/MI and MI-alone contact allergies have risen markedly worldwide, leading to changes in their use in products. OBJECTIVES The aim of the study was to determine the incidences of positive patch test reactions and factors associated with MCI and/or MI contact allergies during the recent decade in Thailand. METHODS Medical records of patients who underwent patch testing at Siriraj Hospital from 2009 to 2018 were retrospectively reviewed. The incidences of positive reactions, histories, and clinical data of MCI/MI and MI-alone contact allergy patients were analyzed. RESULTS Of 2789 patients undergoing patch testing, most were female (76.1%). The mean ± SD age was 42.7 ± 15.7 years. Positive reactions to MCI/MI increased from 2009 to 2016 before declining. The MCI/MI contact allergy was most common in females, middle-aged patients, and those with metal allergy histories, with the hands and arms being the predominant sites. However, MI-alone contact allergy was more common in males and mainly at the trunk. Its incidence significantly declined for the last 5 years. CONCLUSIONS The incidences of MCI/MI and MI-alone contact allergies began to decline because the Food and Drug Administration Thailand regulations restricted their use. The risk factors for the allergies reported in this study provide important information for patient care.
Collapse
Affiliation(s)
- Thanisorn Sukakul
- From the Department of Dermatology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
| | | | | |
Collapse
|
89
|
Horton E, Wilkinson M, Aalto‐Korte K, Pesonen M, Bauer A, Chowdhury MM, Cooper S, Cousen P, Crépy M, Larese Filon F F, Gallo R, Geier J, Giménez‐Arnau A, Gonçalo M, Goossens A, Green C, Guarneri F, Ljubojević Hadžavdić S, Johansen JD, Johnston GA, Rustemeyer T, Sánchez‐Pérez J, Thyssen JP, Schuttelaar MA, Stone N, Uter W. A survey of members of the European Surveillance System on Contact Allergy and the EU project “StanDerm” to identify allergens tested in cosmetic series across Europe. Contact Dermatitis 2020; 82:195-200. [DOI: 10.1111/cod.13437] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2019] [Revised: 10/15/2019] [Accepted: 11/15/2019] [Indexed: 11/27/2022]
Affiliation(s)
- Emma Horton
- Department of DermatologyChapel Allerton Hospital Leeds UK
| | - Mark Wilkinson
- Department of DermatologyChapel Allerton Hospital Leeds UK
| | - Kristiina Aalto‐Korte
- Occupational MedicineFinnish Institute of Occupational Health (FIOH) Helsinki Finland
| | - Maria Pesonen
- Occupational MedicineFinnish Institute of Occupational Health (FIOH) Helsinki Finland
| | - Andrea Bauer
- Department of DermatologyUniversity Hospital Carl Gustav Carus, Technical University of Dresden Dresden Germany
| | | | - Susan Cooper
- Department of Dermatology, Oxford University Hospitals NHS Foundation Trust Oxford UK
| | - Philippa Cousen
- Department of Dermatology, The James Cook University Hospital Middlesbrough UK
| | - Marie‐Noëlle Crépy
- Department of Occupational MedicineUniversity Hospital of Centre of Paris COCHIN Paris France
| | - Francesca Larese Filon F
- Department of Dermatology, Dipartimento di Scienze Mediche, Chirurgiche e della SaluteUnità Operativa di Medicina del Lavoro, Università di Trieste Trieste Italy
| | - Rosella Gallo
- Department of Dermatology, Section of Dermatology, DISSALUniversity of Genoa Genoa Italy
| | - Johannes Geier
- Department of Dermatology, Information Network of Department of Dermatology (IVDK)Institute at the University Medical Center Goettingen Goettingen Germany
| | - Ana Giménez‐Arnau
- Department of Dermatology, Hospital del MarInstitut Mar d'Investigacions Mediques, Universitat Autónoma Barcelona Spain
| | - Margarida Gonçalo
- Department of Dermatology, Clinic of DermatologyUniversity Hospital and Faculty of Medicine, University of Coimbra Coimbra Portugal
| | - An Goossens
- Department of Dermatology, Universitair Ziekenhuis Leuven Belgium
| | - Cathy Green
- Department of Dermatology, Ninewells Hospital Dundee UK
| | | | - Suzana Ljubojević Hadžavdić
- Department of Dermatology, University Department of Dermatology and VenerologyZagreb University Hospital Center Zagreb Croatia
| | - Jeanne D. Johansen
- Department of Dermatology & Allergy and National Allergy Research CentreHerlev‐Gentofte Hospital Hellerup Denmark
| | | | - Thomas Rustemeyer
- Department of Dermatology and AllergologyAmsterdam University Medical Centres Amsterdam The Netherlands
| | | | - Jacob P. Thyssen
- Dermatology Department of the Hospital de la Princesa Madrid Spain
| | - Marie‐Louise A. Schuttelaar
- Department of DermatologyUniversity Medical Centre Groningen, University of Groningen Groningen The Netherlands
| | - Natalie Stone
- Department of Dermatology, Royal Gwent Hospital Newport UK
| | - Wolfgang Uter
- Department of Medical Informatics, Biometry and EpidemiologyUniversity of Erlangen/Nürnberg Erlangen Germany
| |
Collapse
|
90
|
|
91
|
Thyssen JP, Ahlström MG, Bruze M, Rustemeyer T, Lidén C. Metals. Contact Dermatitis 2020. [DOI: 10.1007/978-3-319-72451-5_35-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
92
|
Contact Allergy to Fragrances. Contact Dermatitis 2020. [DOI: 10.1007/978-3-319-72451-5_86-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
93
|
The European Baseline Series. Contact Dermatitis 2020. [DOI: 10.1007/978-3-319-72451-5_64-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
94
|
|
95
|
|
96
|
Topical Drugs. Contact Dermatitis 2020. [DOI: 10.1007/978-3-319-72451-5_38-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
97
|
Goossens A, Gonçalo M. Contact Allergy to Topical Drugs. Contact Dermatitis 2020. [DOI: 10.1007/978-3-319-72451-5_38-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
98
|
|
99
|
Comments on Various Baseline Series. Contact Dermatitis 2020. [DOI: 10.1007/978-3-319-72451-5_95-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
100
|
Comments on Various Baseline Series for Patch Testing. Contact Dermatitis 2020. [DOI: 10.1007/978-3-319-72451-5_95-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|